We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$254B
AUM Growth
+$235B
Cap. Flow
+$230B
Cap. Flow %
90.52%
Top 10 Hldgs %
17.14%
Holding
3,268
New
2,228
Increased
916
Reduced
59
Closed
11

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$8.24B
2
AAPL icon
Apple
AAPL
+$6.76B
3
AMZN icon
Amazon
AMZN
+$6.52B
4
META icon
Meta Platforms (Facebook)
META
+$4.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.45B

Sector Composition

Rank Sector Weight
1 Technology 18.97%
2 Financials 14.46%
3 Healthcare 12.78%
4 Consumer Discretionary 10.65%
5 Industrials 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMNB icon
2551
Farmers National Banc Corp
FMNB
$930M
$1.55M ﹤0.01%
+104,377
New +$1.48M
CONN
2552
DELISTED
Conn's Inc.
CONN
$1.54M ﹤0.01%
+86,712
New +$1.91M
TTI icon
2553
TETRA Technologies
TTI
$1.26B
$1.54M ﹤0.01%
+944,179
New +$1.9M
URGN icon
2554
UroGen Pharma
URGN
$2.29B
$1.54M ﹤0.01%
+42,826
New +$1.58M
HIFS icon
2555
Hingham Institution for Saving
HIFS
$663M
$1.54M ﹤0.01%
+7,761
New +$1.43M
CTLP
2556
DELISTED
Cantaloupe
CTLP
$1.54M ﹤0.01%
+206,807
New +$1.28M
WTBA icon
2557
West Bancorporation
WTBA
$485M
$1.54M ﹤0.01%
+72,411
New +$1.54M
AKCA
2558
DELISTED
Akcea Therapeutics Inc
AKCA
$1.53M ﹤0.01%
+65,422
New +$1.62M
IMGN
2559
DELISTED
Immunogen Inc
IMGN
$1.53M ﹤0.01%
705,551
+636,449
+921% +$1.51M
BY icon
2560
Byline Bancorp
BY
$1.76B
$1.53M ﹤0.01%
+79,875
New +$1.53M
AMTB icon
2561
Amerant Bancorp
AMTB
$1.13B
$1.52M ﹤0.01%
+76,956
New +$1.36M
CPRX
2562
DELISTED
Catalyst Pharmaceutical
CPRX
$1.51M ﹤0.01%
+394,565
New +$1.7M
CIA icon
2563
Citizens
CIA
$192M
$1.51M ﹤0.01%
+207,350
New +$1.42M
EQBK icon
2564
Equity Bancshares
EQBK
$1.05B
$1.51M ﹤0.01%
+56,758
New +$1.51M
CUTR
2565
DELISTED
Cutera, Inc.
CUTR
$1.5M ﹤0.01%
+72,423
New +$1.29M
SWAV
2566
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$1.5M ﹤0.01%
+26,262
New +$1.28M
CRBP icon
2567
Corbus Pharmaceuticals
CRBP
$190M
$1.5M ﹤0.01%
+7,194
New +$1.54M
CRMD icon
2568
CorMedix
CRMD
$584M
$1.49M ﹤0.01%
+166,541
New +$1.31M
PDFS icon
2569
PDF Solutions
PDFS
$2.07B
$1.49M ﹤0.01%
+113,826
New +$1.46M
AMNB
2570
DELISTED
American National Bankshares Inc
AMNB
$1.49M ﹤0.01%
+38,317
New +$1.38M
OLBK
2571
DELISTED
Old Line Bancshares, Inc.
OLBK
$1.48M ﹤0.01%
+55,773
New +$1.42M
CFMS
2572
DELISTED
Conformis, Inc. Common Stock
CFMS
$1.48M ﹤0.01%
+13,576
New +$1.12M
TBIO
2573
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$1.48M ﹤0.01%
+117,144
New +$1.23M
BFIN
2574
DELISTED
BankFinancial
BFIN
$1.47M ﹤0.01%
+105,313
New +$1.53M
RYAM icon
2575
Rayonier Advanced Materials
RYAM
$610M
$1.47M ﹤0.01%
+226,802
New +$2.36M

Similar funds

Nuveen's Q2 2019 Portfolio in Review

As of Q2 2019, Nuveen held 3,268 positions worth $254B, up 1,256% from $18.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Nuveen deployed $230B of net new capital in Q2 2019, opening 2,228 new positions and adding to 916 existing holdings. Its largest new stake was Netflix: 33,941,080 shares worth $1.25B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $142M trimmed.

  • Nuveen's largest Q2 2019 buy was Netflix: 33,941,080 shares worth $1.25B.
  • Nuveen added most to Microsoft in Q2 2019, an estimated $8.24B increase.
  • Nuveen's biggest Q2 2019 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $142M.
  • Nuveen fully exited Nuveen ESG Large-Cap Value ETF in Q2 2019, selling an estimated $22M.
  • Nuveen's ten largest holdings make up 17% of its $254B portfolio in Q2 2019.
  • Nuveen opened 2,228 new positions and closed 11 in Q2 2019.
  • Nuveen's portfolio value rose 1,256% quarter-over-quarter to $254B.

Based on Nuveen's 13F filing for Q2 2019, filed 15 Aug 2019.